EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeting Urease: A Promising Adjuvant Strategy for Effective Helicobacter pylori Eradication

Shivani Kunkalienkar iD, Neha S Gandhi iD, Ashutosh Gupta, Moumita Saha, Aravinda Pai, Shiran Shetty, Abhishek Gupta iD, Namdev Dhas, Raghu Chandrashekar Hariharapura, K Nandakumar iD, Nagalakshmi Narasimhaswamy, Sudheer Moorkoth iD

ACS Omega · 15.07.2025 · 10 (27) · 28643-28669

DOI: 10.1021/acsomega.5c02725 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ACS Omega, online erschienen am 04.07.2025. Verfasst von Shivani Kunkalienkar und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Quality Assurance, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal 576 104, Kar…. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 184 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Indian Council of Medical Research (ICMR), New Delhi, Goverment of India.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Helicobacter pylori, a Gram-negative bacterium, exhibits unique adaptations to thrive in an acidic gastric environment. Urease enzyme present in the bacteria converts urea to ammonia and carbon dioxide, making the surrounding acidic environment of the bacteria neutral. This adaptation helps the bacteria to survive and travel further to gastric epithelial cells, where it attaches to mucin and damages the tissues, leading to gastritis, peptic ulcer, and ultimately, cancer. Physicians typically prescribe first-, second-, and third-line antibiotic therapies to eliminate the bacterium, but these treatments frequently fail to achieve complete eradication. This failure, driven by factors such as the coccoid form, high bacterial load, and biofilm formation, contributes to the growing problem of antibiotic resistance. Targeting urease activity presents a promising strategy to reduce the H. pylori pathogenicity and enhance its susceptibility to antibiotics. Inhibiting urease enzyme activity would be an option to make the bacteria less pathogenic and more prone to antibiotic treatment. Including the urease inhibitors as an adjuvant with the current antibiotic treatment regimen would effectively eradicate the bacteria. This comprehensive review discusses the structural characteristics of the urease enzyme and its role in pathogenesis and the available urease inhibitors along with their pharmacophoric features. An elaborative pharmacophore-based screening and docking study on scaffolds such as chlorogenic acid, catechol, and hydroxamic acid to discover a potent urease inhibitor is a future scope identified in this review.

Autor:innen und Institutionen

  • Department of Pharmaceutical Quality Assurance, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal 576 104, Karnataka, India.
  • Department of Biotechnology, Manipal Institute of Technology, Manipal Academy of Higher Education, Manipal 576 104, India.
  • Department of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal 576 104, Karnataka, India.
  • Department of Gastroenterology and Hepatology, Kasturba Medical College, Manipal Academy of Higher Education, Manipal 576 104, Karnataka, India.
  • School of Pharmacy and Life Sciences, Faculty of Science and Engineering, University of Wolverhampton, Wulfruna Street, Wolverhampton WV1 1LY, U.K.
  • Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal 576 104, Karnataka, India.

ORCID-Profile: Shivani Kunkalienkar, Neha S Gandhi, Abhishek Gupta, K Nandakumar, Sudheer Moorkoth

Förderung

  • Indian Council of Medical Research (ICMR), New Delhi, Goverment of India

Zitieren

APA

Kunkalienkar, S., Gandhi, N. S., Gupta, A., Saha, M., Pai, A., Shetty, S., Gupta, A., Dhas, N., Hariharapura, R. C., Nandakumar, K., Narasimhaswamy, N., & Moorkoth, S. (2025). Targeting Urease: A Promising Adjuvant Strategy for Effective Helicobacter pylori Eradication. ACS Omega, 10(27), 28643-28669. https://doi.org/10.1021/acsomega.5c02725

Vancouver

Kunkalienkar S, Gandhi NS, Gupta A, Saha M, Pai A, Shetty S, et al. Targeting Urease: A Promising Adjuvant Strategy for Effective Helicobacter pylori Eradication. ACS Omega. 2025;10(27):28643-28669. doi:10.1021/acsomega.5c02725

BibTeX
@article{Kunkalienkar2025,
  author = {Kunkalienkar, Shivani and Gandhi, Neha S and Gupta, Ashutosh and Saha, Moumita and Pai, Aravinda and Shetty, Shiran and Gupta, Abhishek and Dhas, Namdev and Hariharapura, Raghu Chandrashekar and Nandakumar, K and Narasimhaswamy, Nagalakshmi and Moorkoth, Sudheer},
  title = {Targeting Urease: A Promising Adjuvant Strategy for Effective Helicobacter pylori Eradication},
  journal = {ACS Omega},
  year = {2025},
  volume = {10},
  number = {27},
  pages = {28643--28669},
  doi = {10.1021/acsomega.5c02725}
}
Kostenlos starten →